BMC
DNLI icon

Bear Mountain Capital’s Denali Therapeutics DNLI Stock Holding History

Bear Mountain Capital’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$494 Buy
+22
New +$452 ﹤0.01% 163

Other funds holding DNLI

New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
EOJOAM
E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
YMRC
Yorktown Management & Research Company Forest, Virginia $163M AUM 68.53% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
SOAM
SBI Okasan Asset Management Tokyo, Japan $3.04B AUM
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Bear Mountain Capital's DNLI Position: Q2 2026 in Review

Bear Mountain Capital opened a new position in Denali Therapeutics (DNLI) in Q2 2026: 22 shares worth $494. The stake represents ﹤0.01% of the portfolio and ranks #163 among its holdings.

50 funds tracked by Wall St. Rank hold DNLI as of Q2 2026.

  • Bear Mountain Capital held 22 shares of Denali Therapeutics worth $494 as of Q2 2026.
  • Denali Therapeutics was a new Bear Mountain Capital position in Q2 2026.
  • Denali Therapeutics made up ﹤0.01% of Bear Mountain Capital's portfolio in Q2 2026, its #163 holding.
  • 50 funds tracked by Wall St. Rank held Denali Therapeutics as of Q2 2026.

Based on Bear Mountain Capital's 13F filing for Q2 2026, filed 20 Jul 2026.